Comments
Serum Institute of India’s CEO, Adar Poonawalla, on Tuesday said that the Covid vaccine Covovax is now available for children across the country.
Poonawalla tweeted, “Covovax (@Novavax), is now available for children in India. This is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of >90%. This is in line with Shri @narendramodi Ji’s vision of providing yet another vaccine to protect our children.”
Official sources on Monday had said children aged 12-17 years could now get the Covovax at private centres, with a dose costing ₹225 plus GST, in addition to the hospital service charge of ₹150.
The move followed the recommendation of the National Technical Advisory Group on Immunisation (NTAGI) that the Covid-19 jab can be administered for children aged 12-17 years.
Restricted use in emergency
India’s drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12-17 age group, subject to certain conditions, on March 9.
The Covovax vaccine is approved for restricted use in an emergency situation that may prevent Covid-19 in individuals 12 years of age and older. According to Serum Institute, during the ongoing clinical trials, the Covovax vaccine had been shown to prevent Covid-19 following two doses given three weeks apart.
The duration of protection against Covid-19 disease is currently unknown. Protection against Covid-19 starts approximately seven days after the second dose of Covovax.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.